The Expression of CD14⁺CD16⁺ Monocyte Subpopulation in Coronary Heart Disease Patients with Blood Stasis Syndrome

Table 1

Characteristics of the CHD patients with BSS/non-BSS and healthy individuals participated in the study.

	CHD patients
	BSS patients	Non-BSS patients	Healthy control	𝑃 value
	(𝑛=50)	(𝑛=50)	(𝑛=40)
Age (year)	53.00±6.43	52.92±6.03	49.50±8.71	0.507
Sex (male/female)	36/14	33/17	28/12	0.804
BMI (kg/m^2)	25.50±2.77	25.10±2.57	24.29±1.57	0.509
SAP (𝑛)	12	13	—	—
ACS (𝑛)	38	37	—	—
UAP (𝑛)	31	31	—	—
AMI (𝑛)	7	6	—	—
Hypercholesterolemia (>230 mg/dL) (yes/no)	7/43	5/45	—	—
Hypertension (yes/no)	31/19	30/20	—	—
Diabetes (yes/no)	20/30	20/30	—	—
Monocyte count (mmol/L)	0.38±0.11	0.37±0.20	0.36±0.11	0.891

BMI: body mass index; SAP: stable angina pectoris; ACS: acute coronary syndrome; UAP: unstable angina; AMI: acute myocardial infarction. Data are expressed as mean ± SD.